- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03653143
JASPER Intervention in Down Syndrome
Pilot Study of JASPER in Down Syndrome
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Confirmed diagnosis of Trisomy 21
- Age 24-48 months
- Able to walk independently across a room
- Uses at least 5 words / signs
- English speaking
- Parent able to accompany participant to all study visits
Exclusion Criteria:
-Diagnosis of Mosaic / Translocation Down syndrome
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Treatment Group
Assessment #1 Baseline Visit >> 3 month JASPER intervention (weekly) >> Assessment #2 Research Visit >> 3 month treatment as usual >> Assessment #3 Research Visit
|
JASPER is a therapist and parent-mediated intervention that (1) targets the foundations of social communication, (2) uses naturalistic behavioral strategies to increase the rate and complexity of social communication and (3) includes parents as implementers of the intervention to promote generalization across settings and to ensure maintenance.
This intervention is individualized and centered around two key developmental domains critical for social communication function: joint engagement and joint attention.
|
EXPERIMENTAL: Control/Wait-list Group
Assessment #1 Baseline Visit >> 3 month treatment as usual >> Assessment #2 Research Visit >> 3 month JASPER intervention >> Assessment #3 Research Visit
|
JASPER is a therapist and parent-mediated intervention that (1) targets the foundations of social communication, (2) uses naturalistic behavioral strategies to increase the rate and complexity of social communication and (3) includes parents as implementers of the intervention to promote generalization across settings and to ensure maintenance.
This intervention is individualized and centered around two key developmental domains critical for social communication function: joint engagement and joint attention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Joint Engagement
Time Frame: Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Joint engagement will be measured by coded videos of the Caregiver Child Interaction (CCX) session.
CCX measures the amount of time that parent and child engage during a play session.
|
Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in cognition
Time Frame: Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
For in-person participation only, composite scores from the Mullen Scales of Early Learning (MSEL) will be used to measure cognition and language development.
Composite scores are calculated averages based on MSEL subscales 1) Gross motor 2) Visual reception 3) Fine motor 4) Receptive language 5) Expressive language.
Higher composite scores are associated with higher cognitive and language functioning.
|
Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Change in language, socialization, problem behavior, adaptive skills (part a)
Time Frame: Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Subscales of the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) will be used to measure language, socialization, problem behaviors and adaptive skills.
VABS-II subscales include 1) Communication 2) Daily living skills 3) Socialization, and 4) Motor skills.
Behavior frequency is measured on a range of 0=Never to 1=Sometimes to 2=Usually.
|
Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Change in language, socialization, problem behavior, adaptive skills (part b)
Time Frame: Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
The Aberrant Behavior Checklist-Community (ABC-C) will also be used to measure language, socialization, problem behavior, and adaptive skills for in-person participation. ABC-C subscales include 1) Irritability 2) Lethargy 3) Stereotypy 4) Hyperactivity, and 5) Inappropriate speech and are measured on a range of 0=not at all a problem to 3=the problem is severe in degree. The MacArthur-Bates Communicative Development Inventories (MB-CDI) will replace the ABC-C for virtual participation. The MB-CDI is a parent report instrument that captures important information about children's developing abilities in early language, including 1) Vocabulary comprehension 2) Production 3) Gestures, and 4) Grammar. |
Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Change in social-communication skills (part a)
Time Frame: Administered at baseline assessment #1 (0 months) and assessment visit #3 (6 months)
|
Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) will be used to measure social communication skills for in-person participation. ADOS-2 subscales include areas like 1) Language and communication and 2) Reciprocal social interaction. Items within each subscale are scored on unique ranges starting with 0=closest to mastery of behavior. The Autism Diagnostic Interview - Revised (ADI-R) will replace the ADOS for virtual participation. The ADI-R is a comprehensive parent interview that focuses on three functional domains of behavior that are not typically present in individuals without autism spectrum disorder. The three domains are: Language/Communication, Reciprocal Social Interactions, and Restricted, Repetitive, and Stereotyped Behaviors and Interests. |
Administered at baseline assessment #1 (0 months) and assessment visit #3 (6 months)
|
Change in social-communication skills (part b)
Time Frame: Administered at baseline assessment #1 (0 months) and assessment visit #3 (6 months)
|
The Early Social Communication Scales (ESCS) is an experimental measurement that measures change in social-communication skills. It will be used for in-person participation only. The ESCS uses tasks to measure the frequency of initiation of and response to 1) Joint attention 2) Behavioral requests, and 3) Social interaction. The PICS will replace the ESCS for virtual participation. The PICS uses photographs to aid caregivers in understanding and identifying the specific behaviors of interest. Modeled after the ESCS, the PICS assesses various forms and functions of triadic attention in young children. |
Administered at baseline assessment #1 (0 months) and assessment visit #3 (6 months)
|
Change in joint attention skills
Time Frame: Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
The Caregiver Child Interaction sessions (CCX) and Early Social Communication Scales (ESCS) or Pictorial Infant Communication Scale (PICS) will be used to measure changes in joint attention skills.
ESCS, which will only be used for in-person participation, uses tasks to measure the frequency of the child's initiation and response (see above).
The PICS will replace the ESCS for virtual participation.
The PICS uses photographs to aid caregivers in understanding and identifying the specific behaviors of interest.
Modeled after the ESCS, the PICS assesses various forms and functions of triadic attention in young children.
The CCX, which will be used for in-person and virtual participation, measures the amount of time that parent and child engage during a play session.
|
Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Change in play levels
Time Frame: Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Flexibility and diversity of play will be coded from the Structured Play Assessment (SPA) for in-person participation only.
Different toys are presented to the child, and play interaction is measured in terms of 1) Functional play types 2) Symbolic play types, and 3) Play level.
|
Administered at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in social-communication skills (in relation to electrophysiology)
Time Frame: EEG will be measured at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Resting state electroencephalogram (EEG) power will be measured as a potential moderator of treatment on change in joint engagement (baseline to end of treatment).
EEG procedures will be conducted using a previously established JASPER EEG protocol.
|
EEG will be measured at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Change in social-communication skills (in relation to electrophysiology)
Time Frame: ERP visual, auditory, and face processing will be measured at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Electroencephalogram (EEG) is brain monitoring method that will be used to measure brain activity.
EEG power will first be measured during "resting state".
Brain activity in response to low-level visual processing, low-level auditory processing, and face processing will then be measured using event-related potentials (ERPs).
|
ERP visual, auditory, and face processing will be measured at baseline assessment #1 (0 months), assessment visit #2 (3 months), and assessment visit #3 (6 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nicole Baumer, MD, MEd, Boston Children's Hospital
Publications and helpful links
General Publications
- Kasari C, Freeman S, Paparella T. Joint attention and symbolic play in young children with autism: a randomized controlled intervention study. J Child Psychol Psychiatry. 2006 Jun;47(6):611-20. doi: 10.1111/j.1469-7610.2005.01567.x. Erratum In: J Child Psychol Psychiatry. 2007 May;48(5):523.
- Kasari C, Gulsrud A, Freeman S, Paparella T, Hellemann G. Longitudinal follow-up of children with autism receiving targeted interventions on joint attention and play. J Am Acad Child Adolesc Psychiatry. 2012 May;51(5):487-95. doi: 10.1016/j.jaac.2012.02.019. Epub 2012 Apr 6.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Intellectual Disability
- Abnormalities, Multiple
- Chromosome Disorders
- Chromosome Aberrations
- Aneuploidy
- Chromosome Duplication
- Syndrome
- Down Syndrome
- Trisomy
Other Study ID Numbers
- IRB-P00025806
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome, Trisomy 21
-
Axis Shield Diagnostics LtdThe Clinical Trial CompanyCompletedTrisomy 21 in Fetus | Trisomy 18 in Fetus | Trisomy 13 in FetusUnited Kingdom
-
University of PennsylvaniaSequenom, Inc/Laboratory Corporation of America HoldingsCompleted
-
BioCeryxUniversity of British Columbia; University College London Hospitals; Brugmann... and other collaboratorsUnknownTrisomy 21 and Other Fetal AneuploidyAustralia, United Kingdom, Spain, Canada, Belgium, Portugal
-
Assistance Publique - Hôpitaux de ParisCompletedTrisomy 21 - TranslocationFrance
-
Assistance Publique - Hôpitaux de ParisCompletedTrisomy 21, 18 and 13 ScreeningFrance
-
Eastern Mediterranean UniversityCompletedDown Syndrome, Trisomy 21Cyprus
-
Natera, Inc.CompletedTrisomy 21 | Trisomy 18 | Trisomy 13 | Vanishing TwinUnited States
-
Cindy CisnerosCompletedDown Syndrome | Aneuploidy | Trisomy 21 | Trisomy 18 | Trisomy 13United States
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval University; Genome British... and other collaboratorsCompletedTrisomy 21 | Trisomy 18 | Trisomy 13Canada
-
PerkinElmer, Wallac OyAzienda Ospedaliera Città della Salute e della Scienza di TorinoUnknownTrisomy 21 | Trisomy 18 | Trisomy 13Italy
Clinical Trials on JASPER
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesSimons FoundationRecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesRecruiting
-
University of California, Los AngelesCompletedChildren at Risk for ASDUnited States
-
University of California, Los AngelesNational Institutes of Health (NIH)RecruitingAutism Spectrum DisorderUnited States
-
University of California, Los AngelesUniversity of Massachusetts, WorcesterRecruiting
-
Boston Children's HospitalRecruitingDown SyndromeUnited States
-
Boston University Charles River CampusUniversity of California, Los Angeles; University of Chicago; Boston Medical... and other collaboratorsActive, not recruiting
-
University of California, Los AngelesRecruiting
-
Vanderbilt UniversityUniversity of California, Los AngelesCompletedDown Syndrome | Language ImpairmentUnited States